Drugmakers worldwide are rushing to develop treatments and vaccines for the illness that has caused more than 371,000 deaths globally.
Celltrion has research experience with other types of coronavirus conditions such as Middle East Respiratory Syndrome (MERS). It hopes to commence first in-human clinical trials for the COVID-19 treatment in July, said Kwon Ki-Sung, head of the firm’s research and development unit.
https://www.reuters.com/article/us-health-coronavirus-treatment-celltrio/south-koreas-celltrion-says-covid-19-drug-shows-drop-in-viral-load-in-animal-testing-idUSKBN238116
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.